McGann M, Sacco A, Barnachea L. Evaluation of Extended-Release Oxycodone Administered through Enteral Tubes for the Management of Pain in Patients with Head and Neck Cancer: A Case Series [published online ahead of print, 2021 Sep 10]. J Pain Palliat Care Pharmacother. 2021;1-6. doi:10.1080/15360288.2020.1830224
Pub Category: Efficacy
Takemura M, Niki K, Okamoto Y, et al. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biol Pharm Bull. 2021;44(9):1286-1293. doi:10.1248/bpb.b21-00212
Überall MA, Elling C, Eibl C, et al. Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry [published online ahead of print, 2021 Aug 11]. Pain Manag. 2021;10.2217/pmt-2021-0058. doi:10.2217/pmt-2021-0058
Sloan G, Alam U, Selvarajah D, Tesfaye S. The Treatment of Painful Diabetic Neuropathy [published online ahead of print, 2021 Jul 6]. Curr Diabetes Rev. 2021;10.2174/1573399817666210707112413. doi:10.2174/1573399817666210707112413
Gupta M, Knezevic NN, Abd-Elsayed A, Ray M, Patel K, Chowdhury B. Treatment of Painful Diabetic Neuropathy-A Narrative Review of Pharmacological and Interventional Approaches. Biomedicines. 2021;9(5):573. Published 2021 May 19. doi:10.3390/biomedicines9050573
Vellucci R, De Rosa G, Piraccini E. Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality. Drugs Context. 2021;10:2020-12-9. Published 2021 Apr 19. doi:10.7573/dic.2020-12-9
Freo U, Furnari M, Ambrosio F, Navalesi P. Efficacy and tolerability of tapentadol for the treatment of chronic low back pain in elderly patients. Aging Clin Exp Res. 2021;33(4):973-982. doi:10.1007/s40520-020-01586-0
Erosa SC, Haffey PR, Mehta N, Gulati A. Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: a Systematic Review. Curr Pain Headache Rep. 2021;25(3):18. Published 2021 Feb 25. doi:10.1007/s11916-020-00934-z
Rian T, Skogvoll E, Hofstad J, et al. Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty: a randomized clinical trial. Pain. 2021;162(2):396-404. doi:10.1097/j.pain.0000000000002026
Mateos RG, Bernal DS, Morera LMT, Ferri CM, Escobar AE. Long-Term Effectiveness and Tolerability of Pain Treatment with Tapentadol Prolonged Release. Pain Physician. 2021;24(1):E75-E85.